Elutia Inc. (ELUT)Healthcare | Medical Devices | Gaithersburg, United States | NasdaqCM
0.79 USD
+0.01
(0.659%)
⇧
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 0.79 |
Hot Take ↕ | Oct. 10, 2026, 8:38 a.m. EDT
The immediate outlook is severely compromised by a complete lack of earnings power and deteriorating operational performance. The company is generating negative operating cash flow and free cash flow while reporting negative earnings per share, resulting in a forward P/E that is mathematically invalid due to the loss of profitability. This is not a value opportunity; it is a distressed asset where the business model is currently failing to generate capital. The price action confirms this distress, trading significantly below its 50-day and 200-day moving averages, indicating persistent downward pressure. With no dividend to provide income and a balance sheet showing negative cash generation, there is no margin of safety here. The 'strong buy' analyst recommendation appears to be an outlier or based on speculative potential rather than current reality, as the single data point supporting it cannot override the fundamental reality of a losing company with shrinking revenues. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.064594 |
| AutoTheta | 0.067842 |
| AutoETS | 0.099957 |
| MSTL | 0.100171 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 1.48 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.833 |
| Excess Kurtosis | -0.44 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 27.817 |
| Revenue per Share | 0.282 |
| Market Cap | 35,165,652 |
| Forward P/E | -0.72 |
| Beta | 0.84 |
| Profit Margins | 426.90% |
| Previous Name | Aziyo Biologics, Inc. |
| Website | https://elutia.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.114827216 |
| Address1 | 20 Firstfield Road |
| All Time High | 18.2 |
| All Time Low | 0.5 |
| Ask | 0.81 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 154,290 |
| Average Daily Volume3 Month | 176,935 |
| Average Volume | 176,935 |
| Average Volume10Days | 154,290 |
| Beta | 0.838 |
| Bid | 0.5768 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 0.356 |
| City | Gaithersburg |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.794 |
| Current Ratio | 1.768 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.8099 |
| Day Low | 0.7426 |
| Debt To Equity | 27.817 |
| Display Name | Elutia |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,654,800 |
| Earnings Call Timestamp Start | 1,786,654,800 |
| Earnings Timestamp | 1,786,651,200 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -21,353,000 |
| Ebitda Margins | -1.75948 |
| Enterprise To Ebitda | -0.92 |
| Enterprise To Revenue | 1.619 |
| Enterprise Value | 19,649,648 |
| Eps Forward | -1.1 |
| Eps Trailing Twelve Months | -0.64 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 510 307 9896 |
| Fifty Day Average | 0.84268 |
| Fifty Day Average Change | -0.048679948 |
| Fifty Day Average Change Percent | -0.057768013 |
| Fifty Two Week Change Percent | -11.482721 |
| Fifty Two Week High | 1.385 |
| Fifty Two Week High Change | -0.59099996 |
| Fifty Two Week High Change Percent | -0.42671478 |
| Fifty Two Week Low | 0.5 |
| Fifty Two Week Low Change | 0.29400003 |
| Fifty Two Week Low Change Percent | 0.58800006 |
| Fifty Two Week Range | 0.5 - 1.385 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,602,163,800,000 |
| Float Shares | 29,483,340 |
| Forward Eps | -1.1 |
| Forward P E | -0.7218182 |
| Free Cashflow | -27,474,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 25 |
| Fullday Change | 0.0052000284 |
| Fullday Change Percent | 0.6592328 |
| Fullday Price | 0.794 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.57762 |
| Gross Profits | 7,010,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03578 |
| Held Percent Institutions | 0.43825 |
| Implied Shares Outstanding | 44,289,230 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland. |
| Long Name | Elutia Inc. |
| Market | us_market |
| Market Cap | 35,165,652 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_317199458 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-17 |
| Net Income To Common | -22,433,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 38,456,338 |
| Number Of Analyst Opinions | 1 |
| Open | 0.799 |
| Operating Cashflow | -43,993,000 |
| Operating Margins | -2.43098 |
| Overall Risk | 7 |
| Phone | 240 247 1170 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 0.794 |
| Post Market Time | 1,792,180,984 |
| Prev Name | Aziyo Biologics, Inc. |
| Previous Close | 0.7888 |
| Price Hint | 4 |
| Price To Book | 2.2303371 |
| Price To Sales Trailing12 Months | 2.8976312 |
| Profit Margins | 4.26895 |
| Quick Ratio | 1.014 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.0052000284 |
| Regular Market Change Percent | 0.6592328 |
| Regular Market Day High | 0.8099 |
| Regular Market Day Low | 0.7426 |
| Regular Market Day Range | 0.7426 - 0.8099 |
| Regular Market Open | 0.799 |
| Regular Market Previous Close | 0.7888 |
| Regular Market Price | 0.794 |
| Regular Market Time | 1,792,180,802 |
| Regular Market Volume | 86,251 |
| Return On Assets | -0.34659 |
| Revenue Growth | -0.116 |
| Revenue Per Share | 0.282 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 44,289,230 |
| Shares Percent Shares Out | 0.0002 |
| Shares Short | 9,359 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 16,949 |
| Short Name | Elutia, Inc. |
| Short Percent Of Float | 0.0002 |
| Short Ratio | 0.31 |
| Source Interval | 15 |
| State | MD |
| Symbol | ELUT |
| Target High Price | 5.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 5.0 |
| Target Median Price | 5.0 |
| Total Cash | 19,896,000 |
| Total Cash Per Share | 0.449 |
| Total Debt | 4,380,000 |
| Total Revenue | 12,136,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.9682 |
| Two Hundred Day Average Change | -0.1742 |
| Two Hundred Day Average Change Percent | -0.1799215 |
| Type Disp | Equity |
| Volume | 86,251 |
| Website | https://elutia.com |
| Zip | 20,878 |